No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Demant A/S operates as a prominent international entity within the hearing health and audio technology sectors, extending its reach across Europe, North America, the Pacific region, and Asia. The company's activities are structured into two core divisions: Hearing Healthcare and Communications. The Hearing Healthcare segment focuses on the development, sale, and support of hearing aids, in addition to offering a range of diagnostic tools and associated services. Conversely, the Communications segment delivers headsets for professional contact centers, general office environments, and the gaming industry, all distributed under the EPOS brand. Established in 1904, Demant A/S, which was formerly known as William Demant Holding A/S until its name change in March 2019, maintains its corporate headquarters in Smørum, Denmark.
www.demant.comNo one on the platform currently holds DEMANT.CO.
No tracked institution reports a position in DEMANT.CO as of their last filing.
No one on the platform has traded DEMANT.CO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.6% | 12.3% | 12.1% | — | — | — |
| Rev. Growth % | 2.9% | 9.8% | ||||
| Profit Margin % | 6.7% | 9.9% | 10.6% | |||
| Free Cash Flow Margin % | 14.3% | 13.5% | 11.9% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $26.3B | +15.2% | $13.81 | $12.13–$14.98 | — | 15 |
| 2027 | $28.2B | +7.1% | $16.04 | $14.40–$18.19 | — | 17 |
| 2028 | $30.0B | +6.6% | $18.34 | $16.02–$20.69 | — | 14 |
| 2029 | $31.9B | +6.1% | $20.17 | $19.34–$20.73 | — | 7 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-11 | $5.51 | $5.53 | +0.4% |
| 2026-02-03 | $6.36 | $6.40 | +0.6% |
| 2025-08-12 | $5.70 | $5.28 | -7.4% |
| 2025-05-05 | $6.16 | $7.08 | +14.9% |
| 2024-08-14 | $5.83 | $5.99 | +2.7% |
| 2024-05-06 | $5.97 | $5.81 | -2.7% |
| 2024-02-06 | $4.53 | $5.63 | +24.3% |
| 2023-02-07 | $4.95 |
| $4.61 |
| -6.9% |
| +1.95% |
| $8.6B |
| — |
| GN.COGN Store Nord A/S | $95.00 | +0.96% | $13.8B | — |
| HLUN-B.COH. Lundbeck A/S | $41.62 | -6.81% | $33.0B | — |
Source: Financial Modeling Prep · peers by sector/industry